Cargando…

Nanocarriers as a Tool for the Treatment of Colorectal Cancer

Nanotechnology is a promising tool for the treatment of cancer. In the past decades, major steps have been made to bring nanotechnology into the clinic in the form of nanoparticle-based drug delivery systems. The great hope of drug delivery systems is to reduce the side effects of chemotherapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales:	C. de S. L. Oliveira, Ana Luiza, Schomann, Timo, de Geus-Oei, Lioe-Fee, Kapiteijn, Ellen, Cruz, Luis J., de Araújo Junior, Raimundo Fernandes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399070/ https://www.ncbi.nlm.nih.gov/pubmed/34452282 http://dx.doi.org/10.3390/pharmaceutics13081321

Ejemplares similares

Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal Cancer
por: C. de S. L. Oliveira, Ana Luiza, et al.
Publicado: (2020)

Ceramide and palmitic acid inhibit macrophage-mediated epithelial–mesenchymal transition in colorectal cancer
por: de Araujo Junior, Raimundo Fernandes, et al.
Publicado: (2020)

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022)

Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer
por: Júnior, Raimundo Fernandes de Araújo, et al.
Publicado: (2023)

Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer
por: Meijer, T. Susanna, et al.
Publicado: (2022)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

Ablation margin quantification after thermal ablation of malignant liver tumors: How to optimize the procedure? A systematic review of the available evidence
por: Hendriks, Pim, et al.
Publicado: (2023)

FDG-PET/CT based response-adapted treatment
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2012)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas
por: Kleiburg, Fleur, et al.
Publicado: (2023)

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
por: Dotinga, Maaike, et al.
Publicado: (2022)

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
por: Meijer, T. Susanna, et al.
Publicado: (2019)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

The Value of (18)F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
por: Bijlstra, Okker D., et al.
Publicado: (2022)

The current role of nuclear medicine in breast cancer
por: Vaz, Sofia C., et al.
Publicado: (2023)

Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer
por: Heijmen, Linda, et al.
Publicado: (2015)

Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients
por: Govaert, Stephanie LA, et al.
Publicado: (2012)

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
por: Poels, Thomas T., et al.
Publicado: (2021)

FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
por: de Koster, Elizabeth J., et al.
Publicado: (2021)

Fludeoxyglucose positron emission tomography-computed tomography scan showing polyarthritis in a patient with an atypical presentation of Henoch-Schönlein vasculitis without clinical signs of arthritis: a case report
por: Mooij, Christiaan F., et al.
Publicado: (2016)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET/CT study
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Investigating the potential added value of [(18)F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study
por: Chen, Linda L., et al.
Publicado: (2023)

Environmentally compatible bioconjugated gold nanoparticles as efficient contrast agents for inflammation-induced cancer imaging
por: Garcia, Vinícius Barreto, et al.
Publicado: (2019)

Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[(18)F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
por: van der Bruggen, Wouter, et al.
Publicado: (2021)

Cardiac molecular pathways influenced by doxorubicin treatment in mice
por: Bulten, Ben F., et al.
Publicado: (2019)

Adding the temporal domain to PET radiomic features
por: Noortman, Wyanne A., et al.
Publicado: (2020)

Cerebral [(18)F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring (18)F-FDG-PET/CT
por: Meijer, Tineke W.H., et al.
Publicado: (2018)

STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer
por: Cavalcante, Rômulo S., et al.
Publicado: (2021)

Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer
por: Jorquera-Cordero, Carla, et al.
Publicado: (2022)

Letter to the Editor: Interobserver Variability of Heart-to-Mediastinum Ratio in I-123 MIBG Sympathetic Imaging
por: Bulten, Ben F., et al.
Publicado: (2012)

Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
por: Smeets, Esther M. M., et al.
Publicado: (2019)

Limited clinical value of two consecutive post-transplant renal scintigraphy procedures
por: Benjamens, Stan, et al.
Publicado: (2019)

Can transplant renal scintigraphy predict the duration of delayed graft function? A dual center retrospective study
por: Benjamens, Stan, et al.
Publicado: (2018)

Experimental validation of absolute SPECT/CT quantification for response monitoring in patients with coronary artery disease
por: van de Burgt, Alina, et al.
Publicado: (2021)

EANM practice guideline for quantitative SPECT-CT
por: Dickson, John C., et al.
Publicado: (2022)

Cell-Based Tracers as Trojan Horses for Image-Guided Surgery
por: Sier, Vincent Q., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vi0qnh6tknbat2234btbb3tbtm